How a Mother’s Childhood Trauma May Leave Marks on Her Child’s Biological Clock

When a mother carries the memory of her own childhood trauma into pregnancy, the question of whether that history reaches her child at the molecular level has become one of the most compelling puzzles in modern biology. A team of researchers at the University of Calgary has now mapped the available evidence in a scoping review published in Frontiers in Child and Adolescent Psychiatry, and their findings paint a picture that is as nuanced as it is provocative. After screening 1,441 articles across six major databases, only four studies met the strict criteria required to link maternal adverse childhood experiences, or ACEs, to epigenetic aging markers in children from birth to age 18. The scarcity of qualifying research is itself a finding, revealing how little is known about a process that could shape health across generations.

The review, led by Debjani Chanda and colleagues including Deborah Dewey at the Cumming School of Medicine, focused on a specific molecular technology known as the epigenetic clock. These clocks read patterns of DNA methylation, chemical tags that attach to cytosine-phosphate-guanine sites across the genome and shift in predictable ways as cells age. By comparing the methylation-predicted age to a person’s chronological age, researchers derive a measure called epigenetic age acceleration, or EAA. In adults, accelerated EAA has been linked to frailty, depression, cardiovascular disease, and earlier mortality. But in children, the interpretation becomes far more complicated, because rapid growth and organ maturation blur the line between aging and development.

This distinction matters enormously when studying newborns. The review highlights that gestational age clocks, such as the Knight and Bohlin clocks, estimate gestational age from methylation patterns in cord blood and other perinatal tissues. When the methylation-estimated gestational age deviates from the clinically measured one, researchers call it gestational epigenetic age acceleration, or GEAA. But rather than indicating accelerated aging in the adult sense, GEAA in fetal and neonatal populations may simply reflect differences in developmental timing or fetal maturity. The authors argue that epigenetic age deviations in pediatric populations should be treated as developmentally contextualized biomarkers rather than uniform indicators of biological aging across the life course.

The four studies that survived the rigorous screening process were conducted between 2024 and 2025, three in the United States and one in the United Kingdom. Sample sizes ranged from 80 to 883 maternal-child dyads, and biological samples were collected from birth up to 8 years of age. Tissue types varied widely, including umbilical cord blood, peripheral blood, saliva, and even umbilical vein endothelial cells. The researchers used multiple epigenetic clocks, including the Horvath pan-tissue clock, the pediatric-specific PedBE clock, gestational clocks like Knight and Bohlin, and DunedinPACE, which measures the pace of biological aging rather than a deviation from chronological age. This methodological diversity, while scientifically rich, makes direct comparison across studies nearly impossible.

What emerged from the synthesis is a pattern of context-dependent associations rather than a straightforward dose-response relationship. In the largest study, drawing on the Avon Longitudinal Study of Parents and Children in the UK, total maternal ACE scores showed no significant association with newborn epigenetic age deviation. Yet when researchers broke the data down by sex and specific adversity type, striking patterns appeared. Maternal exposure to any type of neglect, particularly emotional neglect, was associated with higher gestational epigenetic age acceleration in male newborns, while maternal experiences of parental separation or domestic violence were associated with lower GEAA in female newborns. These sex-specific findings align with broader evidence suggesting that male fetuses may be more vulnerable to prenatal adversity and its effects on epigenetic programming.

Racial disparities added another layer of complexity. In a study drawing on the National Heart, Lung, and Blood Institute Growth and Health Study, maternal childhood physical and sexual abuse predicted increased Horvath clock EAA in Black children but not in White children. Children of Black mothers were approximately four months younger epigenetically than their chronological age, while children of White mothers were approximately six weeks older epigenetically. The authors caution that epigenetic clocks are imperfect biomarkers subject to biases based on the training datasets used in their creation, and prediction models can underperform in groups that are underrepresented in those datasets. This means that apparent racial differences in epigenetic aging could reflect variations in clock performance, cellular composition, or environmental exposures rather than inherent biological differences.

Perhaps the most intriguing finding came from a study of 332 maternal-child dyads, where maternal ACEs showed no direct main effects on any of five epigenetic clocks. However, a significant interaction emerged when researchers considered maternal restless sleep during pregnancy. Newborns of mothers who experienced both ACE exposure and moderate-to-severe restless sleep showed accelerated gestational epigenetic age acceleration on the EPIC GA clock, with a mean acceleration of 1.04 weeks. This suggests that the biological embedding of maternal adversity may depend on the broader prenatal environment, with sleep disruption acting as a moderator that amplifies or reveals the molecular consequences of early maternal trauma.

The biological plausibility of these associations rests on several converging pathways. Maternal childhood adversity may produce persistent alterations in hypothalamic-pituitary-adrenal axis function, cortisol regulation, immune activity, and metabolic health, all of which shape the intrauterine environment during a subsequent pregnancy. Altered maternal stress physiology can affect fetal developmental programming through glucocorticoid signaling and epigenetic regulation of stress-responsive genes, including NR3C1 and FKBP5. The placenta, as the maternal-fetal interface, integrates endocrine, immune, metabolic, and environmental signals and regulates fetal exposure to glucocorticoids and other mediators. Maternal stress has been associated with placental methylation changes in genes involved in glucocorticoid signaling, with potential implications for fetal development. Oxidative stress and mitochondrial dysfunction represent additional pathways, as chronic stress is associated with increased reactive oxygen species and impaired antioxidant capacity, which may influence DNA methylation, cellular senescence, and other aging-related processes.

Despite the elegance of these mechanistic models, the review is emphatic that the evidence base remains too thin to draw firm conclusions. Only four studies met the inclusion criteria despite screening more than 1,400 records, which precluded quantitative synthesis and limited the ability to determine whether inconsistencies reflect true biological differences or methodological variation. All four studies relied on maternal retrospective self-reports of childhood adversity, which are susceptible to recall bias and underreporting. Three of the four studies were conducted in the United States, limiting generalizability to populations living in different social, cultural, and healthcare contexts. No eligible studies examined infancy as a distinct developmental window, and only one study included follow-up beyond early childhood, leaving open the question of whether epigenetic age deviations observed at birth persist, attenuate, or transform across development.

The authors conclude that maternal ACEs may be associated with offspring epigenetic aging, but that these associations are complex, context-dependent, and supported by a limited body of evidence. They call for larger, longitudinal studies with greater demographic diversity and methodological consistency, alongside mechanistic investigations of the biological pathways linking maternal adversity to offspring epigenetic aging. Until such evidence accumulates, the role of epigenetic aging in the intergenerational biological embedding of maternal adversity remains uncertain. What is clear is that the molecular echoes of childhood trauma, if they exist, are neither simple nor uniform, and understanding them will require researchers to follow mother-child pairs from pregnancy through childhood and adolescence with repeated epigenetic assessments, a logistical and financial challenge that has so far kept this field in its infancy.

Subject of Research: Intergenerational effects of maternal adverse childhood experiences on epigenetic aging biomarkers in children

Article Title: Maternal adverse childhood experiences and epigenetic aging in pediatric populations: a scoping review

Article References: Maternal adverse childhood experiences and epigenetic aging in pediatric populations: a scoping review. (n.d.). https://doi.org/10.3389/frcha.2026.1913117

Image Credits: AI Generated

DOI: 10.3389/frcha.2026.1913117

Keywords: epigenetic clocks, maternal ACEs, DNA methylation, epigenetic age acceleration, pediatric health, intergenerational trauma, gestational age, biological aging, prenatal programming, scoping review, child development, placental biology